Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
Rheumatology (Oxford)
; 47(4): 552-3, 2008 Apr.
Article
in En
| MEDLINE
| ID: mdl-18281368
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Fibrosis
/
Scleroderma, Systemic
/
Antirheumatic Agents
/
Antibodies, Monoclonal
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Rheumatology (Oxford)
Year:
2008
Document type:
Article